Somatomedin-binding proteins: What role do they play in the growth process?

No abstract is available for this paper.

• Publication year

  1989

• Venue

  European Journal of Pediatrics

• Publication date

  1989-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF01995850PMID 2480240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence of Growth Hormone Dependence and Subunit Structure

  2003cited by this paper
• Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin.

  1989cited by this paper
• Levels of the small insulin-like growth factor-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty.

  1989cited by this paper
• Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.

  1988influential reference
• ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN?

  1988cited by this paper
• Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.

  1988cited by this paper
• Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs.

  1988cited by this paper
• IGF receptors in myocardial capillary endothelium: potential regulation of IGF-I transport to cardiac muscle.

  1988cited by this paper
• The biological and structural characterization of specific serum binding proteins for the insulin-like growth factors.

  1988cited by this paper
• Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions.

  1988cited by this paper
• Primary structure of human insulin‐like growth factor‐binding protein/placental protein 12 and tissue‐specific expression of its mRNA

  1988cited by this paper
• Regulation of the growth hormone-independent growth factor-binding protein in children.

  1988cited by this paper
• Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in the rat.

  1988cited by this paper
• Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph.

  1988cited by this paper
• Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus

  1988cited by this paper
• 31 SOMATOMEDIN BINDING PROTEIN (SmBP) IN NORMALS AND IN GROWTH HORMONE DEFICIENCY (GHD)

  1988cited by this paper
• Isolation and characterization of a cDNA encoding the low molecular weight insulin‐like growth factor binding protein (IBP‐1).

  1988cited by this paper
• Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa.

  1988influential reference
• Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex.

  1988cited by this paper
• An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.

  1987influential reference
• Growth hormone receptor and serum binding protein: purification, cloning and expression

  1987cited by this paper
• Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity.

  1987cited by this paper
• Production of IGF-binding proteins by vascular endothelial cells.

  1987cited by this paper
• Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma.

  1987cited by this paper
• Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man.

  1987cited by this paper
• Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

  1986cited by this paper
• A specific growth hormone-binding protein in human plasma: initial characterization.

  1986cited by this paper
• Paracrine functions of somatomedins.

  1986cited by this paper
• Somatomedin (insulin-like growth factors)-binding proteins. Molecular forms and regulation.

  1986cited by this paper
• Somatomedin-C/insulin-like growth factor I in acromegaly.

  1986cited by this paper
• Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media.

  1986cited by this paper
• Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid.

  1986cited by this paper
• 3 Paracrine functions of somatomedins

  1986cited by this paper
• Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma.

  1986influential reference
• Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma.

  1985cited by this paper
• 6 Factors controlling blood concentration of somatomedin C

  1984cited by this paper
• Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid.

  1984cited by this paper
• Factors controlling blood concentration of somatomedin C.

  1984cited by this paper
• Release of insulin-like growth factors and binding protein activity into serum-free medium of cultured human fibroblasts.

  1984cited by this paper
• Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin.

  1983cited by this paper
• Demonstration that a human hepatoma cell line produces a specific insulin-like growth factor carrier protein.

  1983cited by this paper
• Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status.

  1983cited by this paper
• Production of insulin‐like growth factors and their carrier by rat pituitary gland and brain explants in culture

  1981cited by this paper
• Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy.

  1981cited by this paper
• Release of somatomedin-like activity by cultured WI-38 human fibroblasts.

  1980cited by this paper
• Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.

  1979cited by this paper
• Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity.

  1979cited by this paper
• Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver.

  1979cited by this paper
• The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

  1978cited by this paper
• Primary structure of human insulin‐like growth factor II

  1978cited by this paper
• A human fibrosarcoma cell line producing multiplication stimulating activity (MSA)-related peptides

  1978cited by this paper
• Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

  1977cited by this paper
• The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver.

  1976cited by this paper
• Nonsuppressible insulinlike activity of human serum: purification, physiochemical and biological properties and its relation to total serum ILA.

  1967cited by this paper
• A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.

  1957cited by this paper

• Risk of cancer in patients treated with recombinant human growth hormone in childhood

  2019cites this paper
• Sanfilippo disease (mucopolysaccharidosis type III): Early diagnosis and treatment

  2013cites this paper
• Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease)

  2013cites this paper
• Height velocity and IGF‐I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?

  2002cites this paper
• IGF-I stimulates chemotaxis of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, phosphatidylinositol-3 kinase pathway and plasmin system.

  2000cites this paper
• Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds.

  2000cites this paper
• Low birthweight and adult insulin resistance: the “catch-up growth” hypothesis

  1999cites this paper
• Intrauterine Growth Retardation: Evidence for the Activation of the Insulin-Like Growth Factor (IGF)-Related Growth-Promoting Machinery and the Presence of a Cation-Independent IGF Binding Protein-3 Proteolytic Activity by Two Months of Life

  1998cites this paper
• Neuroblastoma and insulin-like growth factor system. New insights and clinical perspectives.

  1997cites this paper
• Do insulin-like growth factor binding proteins (IGFBPs) modulate the IGF-I growth promoting and differentiating effects in human neuroblastoma cells?

  1996cites this paper
• Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome?

  1995cites this paper
• Is IGF binding protein‐3 assessment helpful for the diagnosis of GH deficiency?

  1995cites this paper
• Linear growth retardation in relation to the three phases of growth.

  1994cites this paper
• Reduced growth hormone secretion in Turner syndrome: is body weight a key factor?

  1994cites this paper
• Growth hormone induces insulin resistance in Laron dwarf cells via lactogenic receptors.

  1993cites this paper
• Glucose does not influence the insulin-like growth factor (IGF) binding to carrier proteins (IGFBPs): Analysis of rat and human serum by western ligand blotting

  1993cites this paper
• Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease.

  1993cites this paper
• The growth hormone deficiency syndrome in adults

  1992cites this paper
• Insulin-like growth factor binding protein 1 (IGFBP-1) levels in Turner syndrome.

  1992cites this paper
• Nutrition and Somatomedin: XXV. Regulation of Insulinlike Growth Factor Binding Protein 1 in Primary Cultures of Normal Rat Hepatocytes

  1991cites this paper
• Insulin-like growth factor I (IGF-I) and growth in children undergoing hemodialysis or after successful renal transplantation.

  1991cites this paper
• Growth hormone metabolism in uremia.

  1991cites this paper
• Human endometrial protein secretion relative to implantation.

  1991cites this paper
• The Endocrine Role of Insulin‐Like Growth Factor I

  1991cites this paper